Health2 years ago
FDA expands approval of contrast agent Cytalux for lung cancer
The U.S. Food and Drug Administration (FDA) has approved paforacyanin (Cytalux) as an injectable contrast agent for adults with lung cancer. of new approvalGranted following priority...
Recent Comments